Evidence map›Paper›PMID 35527025›Full record

Observational studyInternal medicine (Tokyo, Japan)2022

Multiple Types of Taste Disorders among Patients with COVID-19.

Yuta Nanjo, Tomoko Okuma, Yumi Kuroda, Eri Hayakawa, Kohei Shibayama, Takashi Akimoto, Ryoko Murashima, Koichiro Kanamori, Takeo Tsutsumi, Yohei Suzuki and 5 more

Open access · diamondAbstract readObservational Study
In one paragraph

Observational study in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Characteristics of Oral Adverse Effects following COVID-19 Vaccination and Similarities with Oral Symptoms in COVID-19 Patients: Taste and Saliva Secretory Disorders.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Yuta NanjoDepartment of Respiratory Medicine, Juntendo University Graduate School of Medicine, Japan.
Tomoko OkumaDepartment of Respiratory Medicine, Juntendo University Graduate School of Medicine, Japan.
Yumi KurodaDepartment of Respiratory Medicine, Juntendo University Graduate School of Medicine, Japan.
Eri HayakawaDepartment of Respiratory Medicine, Juntendo University Graduate School of Medicine, Japan.
Kohei ShibayamaDepartment of Respiratory Medicine, Juntendo University Graduate School of Medicine, Japan.
Takashi AkimotoDepartment of Respiratory Medicine, Juntendo University Graduate School of Medicine, Japan.
Ryoko MurashimaDepartment of Respiratory Medicine, Juntendo University Graduate School of Medicine, Japan.
Koichiro KanamoriDepartment of Respiratory Medicine, Juntendo University Graduate School of Medicine, Japan.
Takeo TsutsumiDepartment of Respiratory Medicine, Juntendo University Graduate School of Medicine, Japan.
Yohei SuzukiDepartment of Respiratory Medicine, Juntendo University Graduate School of Medicine, Japan.
Yukiko NambaDepartment of Respiratory Medicine, Juntendo University Graduate School of Medicine, Japan.
Fumihiko MakinoDepartment of Respiratory Medicine, Juntendo University Graduate School of Medicine, Japan.
Osamu NagashimaDepartment of Respiratory Medicine, Juntendo University Graduate School of Medicine, Japan.
Shinichi SasakiDepartment of Respiratory Medicine, Juntendo University Graduate School of Medicine, Japan.
Kazuhisa TakahashiDepartment of Respiratory Medicine, Juntendo University Graduate School of Medicine, Japan.
Juntendo University · JPJuntendo University Urayasu Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective Based on the increasing incidence of smell and taste dysfunction among coronavirus disease 2019 (COVID-19) patients, such issues have been considered an early symptom of infection. However, few studies have investigated the type of taste components that are most frequently affected in COVID-19 patients. This study investigated the difference in frequencies of the types of taste component disorders among hospitalized COVID-19 patients. Methods In this retrospective, single-center, observational study, patients' background characteristics, clinical course, laboratory and radiological findings, and details on taste and/or smell disorders were collected and analyzed from medical records. Patients A total of 227 COVID-19 patients were enrolled, among whom 92 (40.5%) complained of taste disorders. Results Multiple types of taste disorders (hypogeusia/ageusia and hypersensitivity, or hypersensitivity and changing tastes) were reported in 10 patients. In particular, 23 patients reported hypersensitivity to at least 1 type of taste, and 2 patients complained of a bitter taste on consuming sweet foods. Impairment of all taste components was found in 48 patients (52.2%). The most frequent taste disorder was salty taste disorder (81 patients, 89.0%). Hypersensitivity to salty taste was most frequently observed (19 patients, 20.9%). Conclusion Patients with COVID-19 develop multiple types of taste disorders, among which salty taste disorder was the most frequent, with many patients developing hypersensitivity to salty taste. As smell and taste are subjective senses, further studies with the combined use of objective examinations will be required to confirm the findings.

Indexed as

AgeusiaCOVID-19DysgeusiaHumansRetrospective StudiesSARS-CoV-2TasteTaste DisordershypersensitivitysaltySARS-CoV-2taste-impaired

Identifiers

PMID35527025
PMCPMC9381347
OpenAlexW4229443617

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.